Posts in category Business Standard
Avanti Feeds consolidated net profit rises 11.50% in the March 2024 quarter (22-05-2024)
Sales rise 17.43% to Rs 1283.51 crore
Goldiam International consolidated net profit rises 10.74% in the March 2024 quarter (22-05-2024)
Sales rise 9.57% to Rs 147.86 crore
Empire Industries standalone net profit declines 7.15% in the March 2024 quarter (22-05-2024)
Sales decline 14.42% to Rs 152.01 crore
Oseaspre Consultants reports standalone net loss of Rs 0.05 crore in the March 2024 quarter (22-05-2024)
Reported sales nil
Swiss Military Consumer Goods consolidated net profit rises 42.77% in the March 2024 quarter (22-05-2024)
Sales rise 37.74% to Rs 54.09 crore
Strides Pharma Science reports consolidated net profit of Rs 18.18 crore in the March 2024 quarter (22-05-2024)
Sales rise 9.90% to Rs 1084.04 crore
Sarthak Metals standalone net profit declines 70.07% in the March 2024 quarter (22-05-2024)
Sales decline 12.58% to Rs 70.65 crore
BCL Industries consolidated net profit declines 4.98% in the March 2024 quarter (22-05-2024)
Sales rise 30.78% to Rs 597.63 crore
Ixigo’s parent firm, Bansal Wire Industries get Sebi’s nod to float IPO (22-05-2024)
Le Travenues Technology Ltd, which operates the travel booking platform ixigo, and steel wire manufacturer Bansal Wire Industries have received Sebi's go-ahead to raise funds through Initial Public Offering (IPOs), an update with the markets regulator showed on Wednesday.
The two companies, which filed their preliminary IPO papers with Sebi in February and March, obtained their observations during May 14-17.
In Sebi's parlance, obtaining observations means the regulator's go-ahead to float public issue.
The Gurugram-based Le Travenues Technology's proposed IPO will be a combination of a fresh issue of equity shares worth Rs 120 crore and an Offer For Sale (OFS) of 6.66 crore equity shares by existing shareholders, according to the Draft Red Herring Prospectus (DRHP).
SAIF Partners India IV Ltd, Peak XV Partners Investments V (formerly known as SCI Investments V), Micromax Informatics Ltd, Placid Holdings, Catalyst Trusteeship Ltd, Madison India Capital HC, Aloke Bajpai and Rajnish
Cipla rallies 4% on US FDA approval to market Lanreotide injection (22-05-2024)
The approval for the generic version of Lanreotide Acetate is in line with Cipla's growth strategy in the complex product segment and will strengthen Cipla's position in the US market.